Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

NCT07284472 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Agitation Associated With Alzheimer's Disease Dementia

Interventions

DRUG: EXV-802
DRUG: Placebo
DRUG: EXV-801

Sponsor

Exciva GmbH